{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T13:54:10Z","timestamp":1649080450237},"reference-count":29,"publisher":"Informa Healthcare","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2013,12,1]]},"DOI":"10.1185\/03007995.2013.842164","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T14:58:02Z","timestamp":1379084282000},"page":"1737-1745","source":"Crossref","is-referenced-by-count":0,"title":["Observational study of ezetimibe discontinuation in primary care practices in the UK"],"prefix":"10.1185","volume":"29","author":[{"given":"Gillian C.","family":"Hall","sequence":"first","affiliation":[{"name":"Grimsdyke House\rRavenscroft Park, LondonUK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vian","family":"Amber","sequence":"additional","affiliation":[{"name":"MSD Ltd, Hoddesdon\rHertsUK"},{"name":"Imperial College\rLondonUK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"O\u2019Regan","sequence":"additional","affiliation":[{"name":"MSD Ltd, Hoddesdon\rHertsUK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Jameson","sequence":"additional","affiliation":[{"name":"MSD Ltd, Hoddesdon\rHertsUK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2013,9,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61778-4"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60104-X"},{"key":"CIT0003","unstructured":"Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. National Institute for Clinical Excellence. 2010. Available at: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG67NICEguideline.pdf [Last accessed January 2013]"},{"issue":"5","key":"CIT0004","first-page":"v1","volume":"91","author":"British Cardiac Society, British Hypertension Society, Diabetes U.K., Heart UK, Primary Care Cardiovascular Society, Association. S","year":"2005","journal-title":"Heart"},{"key":"CIT0005","unstructured":"The management of type 2 diabetes. National Institute for Health and Clinical Excellence. 2009. Available at: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG87NICEGuideline.pdf [Last accessed March 2011]"},{"key":"CIT0006","unstructured":"SIGN 97 risk estimation and the prevention of cardiovascular disease: a national clinical guideline. Scottish Intercollegiate Guidelines Network. 2007. Available at: http:\/\/www.sign.ac.uk\/pdf\/sign97.pdf [Last accessed February 2013]"},{"key":"CIT0007","unstructured":"Identification and management of familial hypercholesterolaemia. National Institute for Clinical Excellence. 2008. Available at: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG071NICEGuideline.pdf [Last accessed December 2012]"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1177\/2047487312450228"},{"key":"CIT0009","unstructured":"Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia. National Institute for Clinical Excellence. 2007. Available at: http:\/\/guidance.nice.org.uk\/TA132 [Last accessed December 2012]"},{"key":"CIT0010","unstructured":"MeReC Extra No.47. National Prescribing Centre. 2010. Available at: http:\/\/www.npc.co.uk\/merec\/cardio\/cdlipids\/resources\/merec_extra_no47.pdf [Last accessed December 2012]"},{"key":"CIT0011","unstructured":"Bedfordshire and Hertfordshire Heart and Stroke Network, 2010. Ezetimibe: Place in therapy: recommendations from the Bedfordshire and Hertfordshire Heart and Stroke Network, NHS Bedford."},{"key":"CIT0012","unstructured":"Ezetimibe \u2013 limited place in therapy incorporating updated NHS Sefton lipid modification guidance. NHS Sefton. Available at: http:\/\/www.seftonpct.nhs.uk\/your-health\/medicines-management\/Prescriber_updates.asp [Last accessed December 2012]"},{"key":"CIT0013","unstructured":"Lipid Modification in Patients With High Risk of CVD. Wirral NHS Foundation Trust. 2009. Available at: http:\/\/www.wirral.nhs.uk\/document_uploads\/Disclosure-Jan2010\/730LipidLoweringGuidelines.pdf [Last accessed March 2012]"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Money, money, money. Drug Therapeut Bull 2010;48:73","DOI":"10.1136\/dtb.2010.05.0036"},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"Ezetimibe \u2013 an update. Drug Therapeut Bull 2009;47:91-5","DOI":"10.1136\/dtb.2009.07.0030"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60739-3"},{"key":"CIT0017","unstructured":"Use of NICE appraised medicines in the NHS in England \u2013 2010 and 2011, experimental statistics. National Institute for Clinical Excellence. 2012. Available at: https:\/\/catalogue.ic.nhs.uk\/publications\/prescribing\/primary\/use-nice-app-med-nhs-exp-stat-eng-10-11\/use-nice-app-med-nhs-exp-stat-eng-10-11-rep.pdf [Last accessed May 2013]"},{"key":"CIT0018","unstructured":"NHS Centre for Coding and Classification. The READ Codes Version 3. London: Stationary Office, 1996"},{"key":"CIT0019","unstructured":"Joint Formulary Committee. British National Formulary 60. London: British Medical Association, Royal Pharmaceutical Society of Great Britain, 2010"},{"key":"CIT0020","unstructured":"Joint Formulary Committee. British National Formulary 63. 2012. Available at: http:\/\/www.bnf.org\/bnf\/bnf\/48\/\/ [Last accessed March 2012]"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.5837\/bjc.2012.003"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-2465"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000145118.55201.15"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.10.1147"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2010.08.026"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.061523"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2011.11.007"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181b442b9"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X219472"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007995.2013.842164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T16:45:19Z","timestamp":1599410719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007995.2013.842164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,23]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12,1]]}},"alternative-id":["10.1185\/03007995.2013.842164"],"URL":"https:\/\/doi.org\/10.1185\/03007995.2013.842164","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,23]]}}}